Journal List > J Korean Ophthalmol Soc > v.58(2) > 1010676

Patrick and Jung: Influence of Preoperative Corneal Endothelial Status on Postoperative Corneal Endothelium Density after Cataract Surgery

Abstract

Purpose

To analyze the influence of preoperative corneal endothelial status on postoperative corneal endothelium density after cataract surgery.

Methods

We evaluated 228 eyes of 158 patients who underwent cataract surgery. Corneal endothelial status and central cor-neal thickness were measured before surgery and 1 day, 1 month, 3 months and 6 months after surgery. Patients were classified by preoperative endothelial cell density (three groups) and their coefficients of variation and hexagonality (two groups). Clinical parameters, including corneal endothelial cell losses, visual acuity, intraocular pressure, spherical equivalent refraction and cen-tral corneal thickness were measured to compare the intergroup indices.

Results

There were no significant differences in corneal endothelial cell losses at 1 day, 1 month, 3 months and 6 months after surgery in any of the groups based on corneal endothelial cell density. There were increases in corneal thickness at 1 day and 1 month after surgery that were significantly higher in the low-endothelial cell density group than the 2,000−2,500 cells/mm2 cell density group ( p < 0.05), but there were no differences after the 3-month time point. There were no significant differences in clin-ical parameters for the coefficient of variation and hexagonality groups until 6 months after surgery.

Conclusions

We observed reversible corneal edema in the low endothelial group; however, there were no significant intergroup differences in corneal endothelial cell loss due to preoperative corneal endothelial status. Our results suggest that cataract sur-gery is relatively safe for patients with morphologically abnormal corneal endothelium and/or low endothelial density; the safety is primarily due to improved equipment and surgery techniques.

References

1. Hodson S. Evidence for a bicarbonate-dependent sodium pump in corneal endothelium. Exp Eye Res. 1971; 11:20–9.
crossref
1. Maurice DM. The location of the fluid pump in the cornea. J Physiol. 1972; 221:43–54.
crossref
1. Dikstein S, Maurice DM. The metabolic basis to the fluid pump in the cornea. J Physiol. 1972; 221:29–41.
crossref
1. Fischbarg J, Lim JJ. Role of cations, anions and carbonic anhy-drase in fluid transport across rabbit corneal endothelium. J Physiol. 1974; 241:647–75.
crossref
1. Geroski DH, Matsuda M, Yee RW, Edelhauser HF. Pump function of the human corneal endothelium Effects of age and cornea guttata. Ophthalmology. 1985; 92:759–63.
1. Waring GO 3rd, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology. 1982; 89:531–90.
1. Bourne WM, Kaufman HE. Specular microscopy of human cor-neal endothelium in vivo. Am J Ophthalmol. 1976; 81:319–23.
crossref
1. Bourne WM, O'Fallon WM. Endothelial cell loss during penetrat-ing keratoplasty. Am J Ophthalmol. 1978; 85:760–6.
crossref
1. Bourne RR, Minassian DC, Dart JK. . Effect of cataract sur-gery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology. 2004; 111:679–85.
1. Hayashi K, Hayashi H, Nakao F, Hayashi F. Risk factors for cor-neal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996; 22:1079–84.
crossref
1. Cameron MD, Poyer JF, Aust SD. Identification of free radicals produced during phacoemulsification. J Cataract Refract Surg. 2001; 27:463–70.
crossref
1. McCarey BE, Edelhauser HF, Lynn MJ. Review of corneal endo-thelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea. 2008; 27:1–16.
crossref
1. Bourne WM, McLaren JW. Clinical responses of the corneal endothelium. Exp Eye Res. 2004; 78:561–72.
crossref
1. Schultz RO, Matsuda M, Yee RW. . Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol. 1984; 98:401–10.
crossref
1. Benetz BA, Lass JH, Gal RL. . Endothelial morphometric pa-rameters to predict endothelial graft failure after penetrating keratoplasty. JAMA Ophthalmol. 2013; 131:601–8.
1. Yang J, Lee JK. Long-term endothelial cell changes after an-gle-supported anterior chamber lens implantation in phakic eyes. J Korean Ophthalmol Soc. 2012; 53:208–14.
crossref
1. Krachmer JH, Mannis MJ, Holland EJ. Cornea. 3rd ed. Vol. 1. St. Louis: MOSBY;2010; 188.
1. Choi JH, Oh HJ, Yoon KC. Long-term results after cataract surgery in patients with low corneal endothelial cell density. J Korean Ophthalmol Soc. 2013; 54:602–9.
crossref
1. Yamazoe K, Yamaguchi T, Hotta K. . Outcomes of cataract sur-gery in eyes with a low corneal endothelial cell density. J Cataract Refract Surg. 2011; 37:2130–6.
crossref
1. Hayashi K, Yoshida M, Manabe S, Hirata A. Cataract surgery in eyes with low corneal endothelial cell density. J Cataract Refract Surg. 2011; 37:1419–25.
crossref
1. Joyce NC. Cell cycle status in human corneal endothelium. Exp Eye Res. 2005; 81:629–38.
crossref
1. Liang H, Zuo HY, Chen JM. . Corneal endothelial cell density and morphology and central corneal thickness in Guangxi Maonan and Han adolescent students of China. Int J Ophthalmol. 2015; 8:608–11.
1. Sopapornamorn N, Lekskul M, Panichkul S. Corneal endothelial cell density and morphology in Phramongkutklao Hospital. Clin Ophthalmol. 2008; 2:147–51.
1. Lee EK, Kim MK, Wee WR, Lee JH. Short-term outcome of cata-ract surgery using torsional-mode phacoemulsification for patients with low endothelial cell counts. J Korean Ophthalmol Soc. 2011; 52:434–41.
crossref
1. Benedetti S, Casamenti V, Benedetti M. Long-term endothelial changes in phakic eyes after Artisan intraocular lens implantation to correct myopia: five-year study. J Cataract Refract Surg. 2007; 33:784–90.
1. Edelhauser HF, Sanders DR, Azar R. . Corneal endothelial as-sessment after ICL implantation. J Cataract Refract Surg. 2004; 30:576–83.
crossref
1. Minassian DC, Rosen P, Dart JK. . Extracapsular cataract ex-traction compared with small incision surgery by phacoemulsifica-tion: a randomised trial. Br J Ophthalmol. 2001; 85:822–9.
crossref

Figure 1.
Comparison of different clinical parameters within subject groups with different cell density. Comparison of best corrected visual acuity (A), spherical equivalent refraction (B), intraocular pressure (C), central corneal thickness (D) and en-dothelial cell loss (E) in subject groups with different cell density. There were no statistically significant differences among the three groups, except in central corneal thickness of 1 day and 1 month after surgery. ECD = endothelial cell den-sity; Pre op = preoperation. * Statistically difference between the ECD < 2,000 cells/mm2 and 2,000-2,500 cells/mm2.
jkos-58-131f1.tif
Figure 2.
Comparison of different clinical parameters within subject groups with different coefficient of variation. Comparison of best corrected visual acuity (A), spherical equivalent re-fraction (B), intraocular pressure (C), central corneal thickness (D) and endothelial cell loss (E) in subject groups with different coefficient of variation. There were no statistically significant differences between the two groups. Pre op = preoperation; CV = coefficient of variation.
jkos-58-131f2.tif
Figure 3.
Comparison of different clinical parameters within subject groups with different hexagonality. Comparison of best corrected visual acuity (A), spherical equivalent refraction (B), intraocular pressure (C), central corneal thickness (D) and endo-thelial cell loss (E) in subject groups with different hexagonality. There were no statistically significant differences between the two groups. Pre op = preoperation; HEX = hexagonality.
jkos-58-131f3.tif
Table 1.
Demographics of the subject groups with different cell density
Group 1 Group 2 Group 3
ECD < 2,000 cells/mm2 ECD 2,000-2,500 cells/mm2 ECD > 2,500 cells/mm2 p-value*
(n = 26) (n = 76) (n = 126)
Age (years) 72.50 ± 9.42 71.67 ± 9.66 63.48 ± 14.92 <0.001
Sex (M:F) 11:15 22:54 42:84 0.451
Best corrected visual acuity (logMAR) 0.40 ± 0.22 0.43 ± 0.26 0.43 ± 0.25 0.923
Spherical equivalent refraction (D) -2.41 ± 4.73 -1.25 ± 3.53 -1.84 ± 5.32 0.570
IOP (mmHg) 15.31 ± 2.53 14.03 ± 3.03 14.36 ± 2.48 0.112
CCT (μ m) 544.89 ± 37.80 535.65 ± 33.34 530.75 ± 29.94 0.108
ECD (cells/mm2) 1,600.58 ± 424.58 2,271.82 ± 132.32 2,789.84 ± 211.13 <0.001
CV 37.38 ± 15.25 35.74 ± 9.51 34.13 ± 10.01 0.063
HEX (%) 45.15 ± 22.39 55.78 ± 29.35 54.00 ± 22.97 0.175
Nucleus sclerosis (LOCS III grade) 2.88 ± 0.59 2.96 ± 0.77 2.73 ± 0.75 0.096
Average phaco power (%) 24.99 ± 3.35 22.54 ± 4.29 23.49 ± 4.25 0.092
Total phaco energy 12.21 ± 7.06 11.16 ± 9.57 9.83 ± 12.22 0.514

Values are presented as mean ± SD unless otherwise indicated.

ECD = endothelial cell density; IOP = intraocular pressure; CCT = central corneal thickness; CV = coefficient of variation; HEX = Hexagonality; LOCS = lens opacities classification system; SD = standard deviation.

* One-way analysis of variance (ANOVA).

Table 2.
Demographics of the subject groups with different coefficient of variation
Groups p-value*
CV < 40 (n = 166) CV ≥ 40 (n = 62)
Age (years) 66.51 ± 13.90 69.50 ± 11.75 0.148
Sex (M:F) 48:118 25:37 0.134
Best corrected visual acuity (logMAR) 0.42 ± 0.24 0.43 ± 0.27 0.899
Spherical equivalent refraction (D) -1.92 ± 4.61 -1.09 ± 5.00 0.326
IOP (mmHg) 14.38 ± 2.75 14.27 ± 2.56 0.781
CCT (μ m) 532.81 ± 32.65 537.54 ± 30.88 0.342
ECD (cells/mm2) 2,510.54 ± 448.90 2,392.50 ± 464.02 0.091
CV 29.90 ± 5.80 47.77 ± 9.04 <0.001
HEX (%) 54.02 ± 25.93 51.98 ± 23.04 0.618
Nucleus sclerosis (LOCS III grade) 2.79 ± 0.74 2.93 ± 0.76 0.232
Average phaco power (%) 23.36 ± 4.44 23.30 ± 3.50 0.936
Total phaco energy 10.71 ± 11.02 10.08 ± 10.47 0.712

Values are presented as mean ± SD unless otherwise indicated.

CV = coefficient of variation; IOP = intraocular pressure; CCT = central corneal thickness; ECD = endothelial cell density; HEX = hex-agonality; LOCS = lens opacities classification system; SD = standard deviation.

* Independent t-test.

Table 3.
Demographics of the subject groups with different hexagonality
Groups
p-value*
HEX < 50 (n = 109) HEX ≥ 50 (n = 119)
Age (years) 67.36 ± 11.88 66.96 ± 14.71 0.823
Sex (M:F) 38:71 37:82 0.575
Best corrected visual acuity (logMAR) 0.44 ± 0.25 0.41 ± 0.24 0.379
Spherical equivalent refraction (D) -1.70 ± 3.98 -1.73 ± 5.27 0.982
IOP (mmHg) 14.38 ± 2.71 14.29 ± 2.65 0.805
CCT (μ m) 537.01 ± 31.89 531.32 ± 32.53 0.188
ECD (cells/mm2) 2,424.87 ± 513.98 2,536.79 ± 387.11 0.067
CV 35.27 ± 10.89 33.13 ± 9.09 0.109
HEX (%) 31.38 ± 14.50 67.33 ± 14.91 <0.001
Nucleus sclerosis (LOCS III grade) 2.91 ± 0.76 2.74 ± 0.72 0.084
Average phaco power (%) 22.96 ± 4.34 23.71 ± 4.08 0.274
Total phaco energy 10.07 ± 9.92 10.79 ± 11.52 0.624

Values are presented as mean ± SD unless otherwise indicated.

HEX = hexagonality; IOP = intraocular pressure; CCT = central corneal thickness; ECD = endothelial cell density; CV = coefficient of var-iation; LOCS = lens opacities classification system; SD = standard deviation.

* Independent t-test.

Table 4.
Multiple regression model for predicting endothelial cell loss (R2 = 0.675)
Variables Beta t p-value
Age 0.533 2.27 0.033
Total phaco energy 5.903 3.46 0.041
TOOLS
Similar articles